ArticleMolecular pharmaceutics2025

Oral Lipid-Based Nanomedicine for the Inhibition of the cGAS-STING Pathway in Inflammatory Bowel Disease Treatment.

Léo Guilbaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.